1.Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S & Murray CJ; Comparative Risk Assessment Collaborating Group (2002) Selected major risk factors and global and regional burden of disease. Lancet 360, 1347–1360.
2.United Nations Administrative Committee on Coordination, Sub-committee on Nutrition (2000) Fourth Report on the World Nutrition Situation: Nutrition Throughout the Life-cycle. Geneva: UN Press.
3.Belperio PS & Rhew DC (2004) Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 116, Suppl. 7A, 27S–43S.
4.DeMaeyer E & Adiels-Tegman M (1985) The prevalence of anemia in the world. World Health Stat Q 38, 302–316.
5.Stoltzfus R, Mullany L & Black RE (2004) Iron deficiency anemia. In Comparative Quantification of Health Risks: The Global and Regional Burden of Disease due to 25 Selected Major Risk Factors, pp. 163–209 [M Ezzati, AD Lopez, A Rodgers and CJL Murray, editors]. Geneva: WHO.
6.Stoltzfus RJ & Dreyfus MJ (1998) Guidelines for the Use of Iron Supplements to Prevent and Treat Iron Deficiency Anemia. Washington, DC: ILSI Press.
7.Lozoff B, Brittenham GM, Wolf AW, McClish DK, Kuhnert PM, Jimenez E, Jimenez R, Mora LA, Gomez I & Krauskoph D (1987) Iron deficiency anemia and iron therapy effects on infant development test performance. Pediatrics 79, 981–985.
8.Beard J (2001) Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr 131, 2 Suppl., 568S–580S.
9.Chandra RK (1973) Reduced bactericidal activity of polymorphs in iron deficiency. Arch Dis Child 48, 864–867.
10.Bhaskaram P & Reddy V (1975) Cell mediated immunity in iron- and vitamin-deficient children. Br Med J iii, 522–524.
11.Mocroft A, Kirk O, Barton S, Dietrich M, Proenca R, Colebunders R, Pradier C, dArminio Monforte A, Ledergerber B & Lundgren JD (1999) Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA Study Group. AIDS 13, 943–950.
12.O’Brien ME, Kupka R, Msamanga GI, Saathoff E, Hunter DJ & Fawzi WW (2005) Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immun Defic Syndr 40, 219–225.
13.Fawzi WW, Msamanga GI, Spiegelman D et al. (1998) Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 351, 1477–1482.
14.Lohman TG, Roche AF & Martorell R (editors) (1988) Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics Publishing.
15.Diggle P, Liang K & Zeger S (1994) Analysis of Longitudinal Data. London: Oxford University Press.
16.Miettinen OS (1985) Theoretical Epidemiology. New York: John Wiley and Sons.
17.Blanche S, Rouzioux C, Moscato ML et al. (1989) A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group. N Engl J Med 320, 1643–1648.
18.Blanche S, Mayaux MJ, Rouzioux C et al. (1994) Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 330, 308–312.
19.Lambert G, Thea DM, Pliner V et al. (1997) Effect of maternal CD4+ cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. New York City Perinatal HIV Transmission Collaborative Study Group. J Pediatr 130, 890–897.
20.Abrams EJ, Wiener J, Carter R, Kuhn L, Palumbo P, Nesheim S, Lee F, Vink P & Bulterys M; Perinatal AIDS Collaborative Transmission Study (PACTS) Group (2003) Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children. AIDS 17, 867–877.
21.Chearskul S, Chotpitayasunondh T, Simonds RJ et al. .; Bangkok Collaborative Perinatal HIV Transmission Study Group (2002) Survival, disease manifestation and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. Pediatrics 110, 25–30.
22.Chatterjee A, Bosch RJ, Hunter DJ, Fataki MR, Msamanga GI & Fawzi WW (2007) Maternal disease stage and child undernutrition in relation to mortality among children born to HIV-infected women in Tanzania. J Acquir Immun Defic Syndr 46, 599–606.
23.Widdowson EM & Spray CM (1951) Chemical development in utero. Arch Dis Child 26, 205–214.
24.Singla PN, Gupta VK & Agarwal KN (1985) Storage iron in human fetal organs. Acta Pediatr Scand 74, 701–706.
25.Burnstein Y, Rashbaum WK, Hatch WC, Calvelli T, Golodner M, Soeiro R & Lyman WD (1992) Alterations in human fetal erythropoiesis are associated with maternal HIV infection. Pediatr Res 32, 155–159.
26.Reed SC, Wirima JJ & Stekeete RW (1994) Risk factors for anemia in young children in rural Malawi. Am J Trop Med Hyg 51, 170–174.
27.Cornet M, Le Hesran JY, Fievet N, Cot M, Personne P, Gounoue R, Beyeme M & Deloron P (1998) Prevalence of and risk factors for anemia in young children in southern Cameroon. Am J Trop Med Hyg 58, 606–611.
28.Adewuyi J & Chitsike I (1994) Hematologic features of the human immunodeficiency virus (HIV) infection in black children in Harare. Cent Afr J Med 40, 333–336.
29.Shaffer N, Hedberg K, Davachi F, Lyamba B, Breman JG, Masisa OS, Behets F, Hightower A & Nguyen-Dinh P (1990) Trends and risk factors for HIV-1 seropositivity among outpatient children, Kinshasa, Zaire. AIDS 4, 1231–1236.
30.Totin D, Ndugwa C, Mmiro F, Perry RT, Jackson JB & Semba RD (2002) Iron deficiency anemia is highly prevalent among human immunodeficiency virus-infected and uninfected infants in Uganda. J Nutr 132, 423–429.
31.Eley BS, Sive AA, Shuttleworth M & Hussey GD (2002) A prospective, cross-sectional study of anemia and peripheral iron status in antiretroviral naïve, HIV-infected children in Cape Town, South Africa. BMC Infect Dis 2, 3.
32.Villamor E, Mbise R, Spiegelman D, Ndossi G & Fazwi WW (2000) Vitamin A supplementation and other predictors of anemia among children from Dar es Salaam, Tanzania. Am J Trop Med Hyg 62, 590–597.
33.Semba RD & Gray GE (2001) The pathogenesis of anemia during human immunodeficiency virus infection. J Invest Med 49, 225–239.
34.Clark TD, Mmiro F, Ndugwa C, Perry RT, Jackson JB, Melikian G & Semba RD (2002) Risk factors and cumulative incidence of anaemia among human immunodeficiency virus-infected children in Uganda. Ann Trop Pediatr 22, 11–17.
35.Ellaurie M, Burns ER & Rubinstein M (1990) Hematologic manifestations in pediatric HIV infection: severe anemia as a prognostic factor. Am J Pediatr Hematol Oncol 12, 449–453.
36.Cross Continents Collaborative for Kids (3Cs4kids) Analysis and Writing Committee (2008) Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS 22, 97–105.
37.Sazawal S, Black RE, Ramsan M et al. (2006) Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomized, placebo-controlled trial. Lancet 367, 133–143.
38.Tielsch JM, Khatry SK, Stotlzfus RJ, Katz J, LeClerq SC, Adhikari R, Mullany LC, Shresta S & Black RE (2006) Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based cluster-randomized, placebo-controlled trial. Lancet 367, 144–152.
39.Pinkerton PH, Spence I, Ogilvie JC, Ronald WA, Marchant P & Ray PK (1970) An assessment of the Coulter counter model S. J Clin Pathol 23, 68–76.
40.Massawe SN, Urassa EN, Mmari M, Ronquist G, Lindmark G & Nystrom L (1999) The complexity of pregnancy anemia in Dar-es-Salaam. Gynecol Obstet Invest 47, 76–82.
41.World Health Organization/Joint United Nations Programme on HIV/AIDS/UNICEF (2008) Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector: Progress Report 2008. Geneva: WHO.